By using BioLensTracker, you agree to use the site for lawful purposes and to treat subscriber updates as general information about our workflow rather than individualized advice.

All content is provided "as is" without warranties. We may update, suspend, or remove site features, subscriber communications, or access terms at any time.

You remain responsible for your own decisions and independent research. BioLensTracker is not liable for outcomes arising from reliance on site content, model outputs, or subscriber messages.

BioLensTracker Clinical Trial Alerts is our subscriber messaging program for Phase 3 and topline clinical trial result alerts.

By providing your phone number and checking the SMS consent box on our website, you agree to receive recurring automated text messages from BioLensTracker Clinical Trial Alerts. Message frequency varies depending on public clinical trial announcements, typically a few messages per month.

Message and data rates may apply. Consent is not a condition of purchase.

For help, reply HELP to any message or contact us at alerts@biolenstracker.com. To stop receiving messages, reply STOP at any time. After you send STOP, you will no longer receive SMS messages unless you opt in again.

These messaging terms apply only to SMS communications that users explicitly request through our website opt-in flow at https://www.biolenstracker.com.